health - "medicine"

Britons are increasingly likely to part with large sums of money for alternative health treatments despite little evidence that they work, writes Johanna Leggatt Alternative therapies tested More health news ...

Posted on: Thursday, 12 June 2008, 12:00 CDT Rules-Based medicine has partnered with Psynova Neurotech to co-develop and commercialize a blood test for the diagnosis of schizophrenia. Rules-Based Med...

The New England Journal of medicine publication showing that Baxter's bird flu candidate vaccine induced neutralizing antibodies against widely divergent H5N1 virus.

St. John's wort is not the answer many hoped for

Researchers from the Case Western Reserve University School of medicine and Penn State Hershey College of medicine identified a novel therapeutic that reduces sterile inflammation within the cornea. Published in the June issue of the Journal of Leukocyte Biology, Dr. Eric Pearlman and Dr. Mark Kester identified a novel ceramide, a natural compound that when delivered in nano-sized packages reduces corneal haze, corneal thickening and inflammation.

A study published this week in the Archives of Internal medicine found an association between low levels of vitamin D and heart attacks in men. Vitamin D is best known...

Researchers at Tufts University School of medicine and Tufts Medical Center have found that Smad proteins regulate microRNA (miRNA) processing. Understanding the role of Smad proteins enables researchers to investigate abnormal miRNA processing which is a contributing factor in development of cardiovascular disorders and cancer. The study was published online in Nature.

The issue of blacks with HIV/AIDS feeling 'comfortable enough and secure enough to openly and publicly disclose their diagnosis is real and deafening and unfortunately contributing to the denial that runs rampant in the African-American community, particularly in the Deep South,' Pamela Payne Foster, deputy director of the University of Alabama School of medicine's Rural health Institute, writes in a

Baxter International Inc. (NYSE: BAX) announced publication in the June 12, 2008 issue of The New England Journal of medicine (NEJM) of data demonstrating Baxter's candidate avian influenza (H5N1) vaccine, CELVAPAN, met Phase I/II trial endpoints for safety and immunogenicity (generating a functional immune response).

In a first-of-its-kind study, research results show that toenail nicotine levels can help predict risk of coronary heart disease (CHD) in women. Researchers at University of California, San Diego, School of medicine, in collaboration with colleagues from Harvard University, showed that the higher the level of nicotine in the toenails, the higher the risk of coronary heart disease, no matter the number of cigarettes smoked or level of exposure to second hand smoke.